High S100A4 expression is associated with poor survival in glioma (Fig. 6g) as well as in breast63,64, bladder65, head and neck, and pancreatic66 cancers, and S100A4 is necessary for breast cancer metastasis67. Here, S100A4 is linked to central nervous system cancer.